KERNW logo
NASDAQ · KERNWMedical - Healthcare Information ServicesUpdated Oct 25, 2026

Akerna Corp. ROE

Profitability, historical returns, and peer comparisons.

The ROE as of October 2026 (TTM) for Akerna Corp. (KERNW) is -20.25%

According to Akerna Corp.’s latest financial reports and current stock price. The company's current ROE is -20.25%. This represents a change of 324.67% compared to the average of -4.77% of the last 4 quarters.

Akerna Corp. (KERNW) Historical ROE (quarterly & annually)

How has KERNW ROE performed in the past?

The mean historical ROE of Akerna Corp. over the last ten years is 192.77%. The current -20.25% ROE has changed -110.50% with respect to the historical average. Over the past ten years (40 quarters), KERNW's ROE was at its highest in in the December 2022 quarter at 243.28%. The ROE was at its lowest in in the June 2022 quarter at -228.40%.

Quarterly (TTM)
Annual

Average

192.77%

Median

-0.01%

Minimum

-58.18%

Maximum

1.21%

Akerna Corp. (KERNW) ROE by Quarter and Year

Discovering the peaks and valleys of Akerna Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 112.71%

Maximum Annual ROE = 1.21%

Minimum Annual Increase = -Infinity%

Minimum Annual ROE = -58.18%

Quarterly (TTM)
Annual
YearROEChange
2025-0.02%-Infinity%
20240%-100.00%
20221.21%-2188.04%
2021-58.18%112.71%
2018-0.05%-Infinity%

Akerna Corp. (KERNW) Average ROE

How has KERNW ROE performed in the past?

The current ROE of Akerna Corp. (KERNW) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

404.96%

5-year avg

231.33%

10-year avg

192.77%

Akerna Corp. (KERNW) ROE vs. Peers

How is KERNW’s ROE compared to its peers?

Akerna Corp.’s ROE is greater than Bellerophon Therapeutics, Inc. (-164.21%), less than Atlantic International Corp. (2.21%), less than Seelos Therapeutics, Inc. (171.72%), less than Virios Therapeutics, Inc. (27.58%), less than MSP Recovery, Inc. (80.67%), greater than CareMax, Inc. (-200.69%), greater than TC Biopharm (Holdings) Plc (-391.64%), greater than Histogen Inc. (-59.67%), greater than FSD Pharma Inc. (-108.36%), greater than Immatics N.V. (-47.04%),

Build a custom stock screener for Akerna Corp. (KERNW) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Akerna Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Akerna Corp. (KERNW) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Akerna Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Akerna Corp.'s ROE?

How is the ROE calculated for Akerna Corp. (KERNW)?

What is the highest ROE for Akerna Corp. (KERNW)?

What is the 3-year average ROE for Akerna Corp. (KERNW)?

What is the 5-year average ROE for Akerna Corp. (KERNW)?

How does the current ROE for Akerna Corp. (KERNW) compare to its historical average?